Cubist Systematic Strategies’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-161,100
| Closed | -$462K | – | 2588 |
|
|
2024
Q1 | $462K | Buy |
161,100
+112,666
| +233% | +$323K | ﹤0.01% | 1411 |
|
|
2023
Q4 | $85.7K | Buy |
+48,434
| New | +$85.7K | ﹤0.01% | 1806 |
|
|
2023
Q1 | – | Sell |
-40,301
| Closed | -$91.1K | – | 3278 |
|
|
2022
Q4 | $91.1K | Buy |
+40,301
| New | +$91.1K | ﹤0.01% | 2868 |
|
|
2022
Q2 | – | Sell |
-33,694
| Closed | -$220K | – | 4037 |
|
|
2022
Q1 | $220K | Buy |
33,694
+14,059
| +72% | +$91.8K | ﹤0.01% | 2980 |
|
|
2021
Q4 | $229K | Buy |
+19,635
| New | +$229K | ﹤0.01% | 2954 |
|
|
2021
Q1 | – | Sell |
-4,453
| Closed | -$118K | – | 2980 |
|
|
2020
Q4 | $118K | Buy |
+4,453
| New | +$118K | ﹤0.01% | 2378 |
|